News & Events


DIA 2018 Is On The Horizon

DIA 2018 Is On The Horizon
31 May 2018

Are you planning to attend DIA 2018 this year? We would love to see you there! Synteract will be exhibiting in Boston in booth #1104, June 24-28th. Our participation in “Driving Insights to Action” will focus on our enhanced Centers of Development in oncology, especially innovative immunotherapy, neuro degenerative disorders, pediatrics, and rare and orphan diseases, and how we can provide full-service clinical trial support in these and other therapeutic indications. We will also be introducing a new bundled services offering that will help everyone who looks forward to submitting their NDA, BLA or MAA.

Come and meet our experts!

Several of our executives and team leaders from California, North Carolina and Europe will be at DIA this year and are available for private appointments. CEO Steve Powell; VP of Pediatric Development Dr. Martine Dehlinger-Kremer; VP of Neuro Degenerative Development Linda Rawlings; and other key operational leadership will be in attendance and available for media interviews. Let us know if would like to request an appointment with any of our experts; just contact Melissa Hays at

We would appreciate the opportunity to show you how our integrated project teams align our operational excellence, deep therapeutic expertise, and the right technology to address your needs and help you navigate the complex process of drug development to bring new medicines to market.

We look forward to seeing you there!


Contact Synteract

Tell us how to stay in touch with you: